While supporters of the Durbin bill today are confident this wouldn't happen, many policy analysts worry that funding the NIH through an alternative stream ultimately would reduce main-line appropriations.
Appropriators will see a trust fund in place and begin decreasing the base investments in the NIH, figuring that the alternative funding will more than adequately fill the coffers.